Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 results

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported Q4 revenue for the quarter at $27.91 million versus the consensus estimate of $24.65 million.

For earnings history and earnings-related data on Mirum Pharmaceuticals, Inc. (MIRM) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance